Table. 1 Baseline and Characteristics
Variable | Bilirubin adsorption (n = 14) | Plasma exchange (n = 42) | P value | ||
|---|---|---|---|---|---|
Age (year) | 62.2 ± 14.9 | 67.2 ± 8.5 | 0.125 | ||
Gender (male, %) | 10, 71.4% | 31, 73.8% | 0.862 | ||
Weight (kg) | 64.4 ± 10.4 | 62.4 ± 8.6 | 0.477 | ||
NYHA class (n, %) | 0.329 | ||||
I | 0 | 0 | |||
II | 0 | 1, 2.3% | |||
III | 6, 42.8% | 23, 54.8% | |||
IV | 8, 57.2% | 18, 42.9% | |||
EuroSCORE II | 30.5 ± 17.5 | 20.9 ± 7.6 | 0.006 | ||
Previous Medical History (n,%) | |||||
Acute Myocardial infarction | 5, 35.7% | 9, 21.4% | 0.285 | ||
Diabetes Mellitus | 7, 50.0% | 11, 26.2% | 0.099 | ||
Chronic Renal Failure | 0 | 0 | — | ||
Hypertension | 11, 78.6% | 24, 26.2% | 0.151 | ||
Liver Disease | 0 | 0 | — | ||
Smoking | 5, 35.7% | 11, 26.2% | 0.495 | ||
Type of cardiac operation (n,%) | 0.890 | ||||
CABG | 1, 7.1% | 4, 9.5% | |||
Valvular surgery | 5, 35.7% | 14, 33.3% | |||
CABG + Valvular surgery | 4, 28.6% | 13, 31.0% | |||
Aortic surgery | 4, 28.6% | 11, 26.2% | |||
CPB time | 251.1 ± 79.7 | 218.1 ± 80.4 | 0.20 | ||
ACC time | 187.8 ± 65.1 | 157.8 ± 58.2 | 0.12 | ||
Pre-operation liver function | |||||
ALT | 29.0 (13.4–58.7) | 25.0.3 (17–51.3) | 0.813 | ||
AST | 34.1 (20.2–109.4) | 30.5 (17.9–37.6) | 0.348 | ||
GGT | 102.8 ± 70.9 | 74.1 ± 38.2 | 0.225 | ||
TBil | 23.3 ± 15.1 | 18.3 ± 9.9 | 0.157 | ||
DBil | 10.3 ± 7.3 | 9.6 ± 6.4 | 0.715 | ||
LDH | 230.9 ± 116.5 | 183.4 ± 83.4 | 0.176 | ||
Serum albumin | 38.7 ± 4.8 | 38.8 ± 3.5 | 0.906 | ||
Pre-operation Serum Creatinine | 115.9 ± 77.5 | 95.4 ± 53.8 | 0.276 | ||